Skip to content
10-K/A

Annual Report

Lantern Pharma Inc. LTRN

0001641172-25-006728

← back to feed
Filed
Apr 30, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Apr 28, 2025 10.78M sh